{
    "Trade/Device Name(s)": [
        "BD ProbeTec ET Chlamydia trachomatis and Neisseria gonorrhoeae Amplified DNA Assays",
        "BD Viper System"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K052481",
    "Predicate Device Reference 510(k) Number(s)": [
        "K984631",
        "K023955"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LSL"
    ],
    "Summary Letter Date": "November 25, 2005",
    "Summary Letter Received Date": "November 16, 2005",
    "Submission Date": "November 15, 2005",
    "Regulation Number(s)": [
        "21 CFR 866.3390"
    ],
    "Regulation Name(s)": [
        "Neisseria spp. direct serological test reagents"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Chlamydia trachomatis DNA",
        "Neisseria gonorrhoeae DNA"
    ],
    "Specimen Type(s)": [
        "Endocervical swabs",
        "Male urethral swabs",
        "Female urine",
        "Male urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD ProbeTec ET System",
        "BD Viper Instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Strand Displacement Amplification (SDA)",
        "Fluorescent energy transfer (ET)"
    ],
    "Methodologies": [
        "Amplified DNA assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Instrument",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for BD Viper System and BD ProbeTec ET Amplified DNA Assays for qualitative detection of Chlamydia trachomatis and Neisseria gonorrhoeae DNA in clinical specimens using SDA and ET technology",
    "Indications for Use Summary": "Qualitative detection of Chlamydia trachomatis and Neisseria gonorrhoeae DNA in endocervical swabs, male urethral swabs, and urine specimens from symptomatic or asymptomatic males and females, as evidence of infection, using strand displacement amplification.",
    "fda_folder": "Microbiology"
}